Abstract
Fabry disease (FD) is an inborn error of metabolism caused by mutations in the GLA gene located on the X chromosome. Defects in this gene lead to the deficiency of ±-galactosidase A (±-Gal A), an enzyme responsible for degrading glycosphingolipids, mainly globotriaosylceramide (Gb3). ±-Gal A is present in all tissues, and its deficiency results in a progressive multisystem disease. FD cov…